Is This Blue Chip Dividend Stock a Buy?

Due to economic concerns, financial markets have fared poorly in 2022. In fact, the S&P 500 index has sunk 17% so far this year.

The good news is that many established dividend-paying stocks have done much better than the broader markets. Up 8% year-to-date, Amgen (NASDAQ: AMGN) is one such stock that has performed well during this time.

But is the dividend stock a buy after its convincing outperformance through the first eight months of the year? Let's dig into Amgen's fundamentals and valuation to address this question.

Continue reading

Source Fool.com